A Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of Intravitreal Fluocinolone (0.6, 2.1 mg) Implant in Patients with Diabetic Macular Edema.

Grants and Contracts Details

StatusFinished
Effective start/end date12/1/00 → 12/31/05

Funding

  • Bausch and Lomb: $538,607.00